Evidence map›Paper›PMID 31314675›Full record

ArticleVirulence2019

A predicted

Gerard J Nau, Joseph Horzempa, Dawn O'Dee, Matthew J Brown, Brian C Russo, Ana Hernandez, Simon T Dillon, Jing Cheng, Lawrence P Kane, Subramaniam Sanker and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Glycosylating Effectors ofBiomolecules · 2022
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Gerard J Naua Division of Infectious Diseases , Alpert Medical School of Brown University , Providence , RI , USA.ORCID 0000-0001-7921-8317
Joseph Horzempab Department of Natural Sciences and Mathematics , West Liberty University , West Liberty , WV , USA.
Dawn O'Deec Department of Microbiology and Molecular Genetics , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Matthew J Brownc Department of Microbiology and Molecular Genetics , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Brian C Russoc Department of Microbiology and Molecular Genetics , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Ana Hernandeza Division of Infectious Diseases , Alpert Medical School of Brown University , Providence , RI , USA.
Simon T Dillond Beth Israel Deaconess Medical Center Genomics, Proteomics, and Systems Biology Center , Harvard Medical School , Boston , MA , USA.
Jing Chenge Department of Immunology , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Lawrence P Kanee Department of Immunology , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Subramaniam Sankerf Department of Developmental Biology , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
Neil A Hukriedef Department of Developmental Biology , University of Pittsburgh School of Medicine , Pittsburgh , PA , USA.
University of Pittsburgh · USBrown University · USBeth Israel Deaconess Medical Center · USWest Liberty University · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Using Genomic Epidemiology to Identify Transmission Patterns and Inform Intervention Strategies for Antibiotic-Resistant N. GonorrhoeaeP20GM121344 · NIGMS · MIRIAM HOSPITAL · PI D'AGATA, ERIKA M · 2018 to 2022
$9.4M
Viral Persistence and PathogenesisT32AI049820 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2001 to 2024
$5.5M
Immunology of Infectious DiseaseT32AI060525 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JoAnne L. Flynn · 2005 to 2026
$5.3M
REPRESSION AND ACTIVATION OF PERSISTING HSV GENOMESR01AI044821 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 1999 to 2016
$4.3M
Biochemical and Spatial Regulation of IKKg/NEMO During T Cell ActivationR01AI103022 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUNNELL, STEPHEN C, KANE, LAWRENCE P. · 2013 to 2017
$3.0M
Regulation of T cell activation and exhaustion by Tim-3R01AI138504 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KANE, LAWRENCE P. · 2018 to 2021
$1.7M
NIAID NIH HHS R01 AI044821NIAID NIH HHS R01 AI103022NIAID NIH HHS R01 AI138504NIAID NIH HHS T32 AI049820NIAID NIH HHS T32 AI060525NIDDK NIH HHS P30 DK079307NIGMS NIH HHS P20 GM121344
6 · The paper itself

Abstract

Pathogens enhance their survival during infections by manipulating host defenses.

Indexed as

Host-Pathogen InteractionsAnimalsBacterial ProteinsCytokinesFemaleFrancisella tularensisGlycosyltransferasesHumansImmunity, InnateJurkat CellsMacrophagesMice, Inbred C57BLMothsMutationTularemiaVirulenceBacterial ProteinsCytokinesGlycosyltransferasesbacterial pathogenesisglycosyltransferasehost-pathogen interactionsinnate immunitymacrophageNFκB

Identifiers

PMID31314675
PMCPMC6650193
OpenAlexW2958134937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.